Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2025-12-29 @ 2:13 AM
Study NCT ID:
NCT06959550
Status:
RECRUITING
Last Update Posted:
2025-11-17
First Post:
2025-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-28
Start Date Type:
ACTUAL
Primary Completion Date:
2028-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-28
First Submit QC Date:
None
Study First Post Date:
2025-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-13
Last Update Post Date:
2025-11-17
Last Update Post Date Type:
ESTIMATED